ArticleHeliyon2023

Effectiveness comparison of third-generation EGFR-TKI as initial and sequential therapy in adjuvant treatment for EGFR mutation-sensitive stage IIIA non-small cell lung cancer after surgery.

Wenyan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.